Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Aliza Brown

Concepts (242)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
12
2020
495
2.070
Why?
Thrombolytic Therapy
8
2020
110
1.160
Why?
Tissue Plasminogen Activator
9
2020
110
1.120
Why?
Endarterectomy, Carotid
9
2011
62
0.870
Why?
Health Services Misuse
1
2020
13
0.690
Why?
Fibrinolytic Agents
7
2020
125
0.690
Why?
Tunica Intima
8
2011
55
0.680
Why?
Homocysteine
7
2011
127
0.640
Why?
Disease Models, Animal
12
2015
1436
0.580
Why?
Pneumonia, Viral
1
2020
169
0.550
Why?
Emergency Service, Hospital
2
2020
484
0.550
Why?
Microbubbles
3
2011
25
0.550
Why?
Coronavirus Infections
1
2020
178
0.550
Why?
Emergency Medical Technicians
1
2016
10
0.530
Why?
Carotid Arteries
6
2010
84
0.530
Why?
Emergency Medical Services
1
2016
110
0.490
Why?
Fluorocarbons
4
2019
58
0.490
Why?
Ultrasonic Therapy
3
2011
34
0.480
Why?
Acetaminophen
3
2011
276
0.460
Why?
Acetylcysteine
2
2011
101
0.460
Why?
Quality Improvement
1
2016
209
0.450
Why?
Cerebral Hemorrhage
3
2015
100
0.390
Why?
Brain Ischemia
4
2019
164
0.380
Why?
Rural Population
1
2016
554
0.380
Why?
Liver Failure, Acute
1
2011
56
0.370
Why?
Intracranial Embolism
2
2012
27
0.370
Why?
Rabbits
10
2016
372
0.360
Why?
Carotid Stenosis
4
2011
63
0.300
Why?
Animals
26
2016
13124
0.290
Why?
Time Factors
11
2020
2935
0.270
Why?
Neuroprotective Agents
2
2019
99
0.270
Why?
Insulin Resistance
2
2010
268
0.260
Why?
Magnetic Resonance Imaging
2
2014
1548
0.250
Why?
Platelet Aggregation Inhibitors
4
2006
174
0.210
Why?
Brain
1
2010
1319
0.190
Why?
Rats
12
2011
3292
0.180
Why?
United States
4
2020
4955
0.180
Why?
Rats, Sprague-Dawley
9
2011
1585
0.180
Why?
Hyperplasia
8
2011
96
0.170
Why?
Conflict of Interest
1
2020
25
0.170
Why?
Male
21
2019
25907
0.170
Why?
Thrombectomy
1
2020
70
0.170
Why?
Disease Outbreaks
1
2020
120
0.160
Why?
Fabry Disease
1
2019
9
0.160
Why?
Enzyme Replacement Therapy
1
2019
17
0.160
Why?
Angiography, Digital Subtraction
2
2011
27
0.160
Why?
Carotid Artery, Common
2
2011
44
0.160
Why?
Ischemic Attack, Transient
1
2019
55
0.160
Why?
Cardiology
1
2020
91
0.150
Why?
Cerebral Angiography
3
2012
97
0.150
Why?
Methylenetetrahydrofolate Reductase (NADPH2)
3
2004
57
0.130
Why?
Infarction, Anterior Cerebral Artery
1
2015
2
0.120
Why?
Pandemics
1
2020
563
0.120
Why?
Infarction, Middle Cerebral Artery
1
2015
40
0.120
Why?
Ticlopidine
2
2006
53
0.120
Why?
Antidotes
2
2011
27
0.120
Why?
Humans
12
2020
50503
0.120
Why?
Receptors, N-Methyl-D-Aspartate
2
2005
127
0.110
Why?
Salivary Proteins and Peptides
2
2004
8
0.110
Why?
L-Lactate Dehydrogenase
1
2014
60
0.110
Why?
Posterior Leukoencephalopathy Syndrome
1
2014
44
0.110
Why?
Fractures, Compression
1
2013
17
0.110
Why?
Fractures, Spontaneous
1
2013
14
0.110
Why?
Models, Animal
4
2011
227
0.110
Why?
Spine
1
2013
90
0.100
Why?
Treatment Outcome
5
2019
5283
0.100
Why?
Telemedicine
1
2019
469
0.100
Why?
Expectorants
1
2011
14
0.100
Why?
Echinomycin
1
2011
6
0.100
Why?
Analysis of Variance
2
2011
552
0.100
Why?
Carotid Artery Injuries
1
2011
13
0.100
Why?
Statistics as Topic
1
2011
88
0.090
Why?
Circle of Willis
1
2011
2
0.090
Why?
Sensitivity and Specificity
2
2011
859
0.090
Why?
Cerebral Infarction
1
2011
37
0.090
Why?
Ultrasonography, Doppler, Transcranial
1
2011
22
0.090
Why?
Intracranial Hemorrhages
1
2011
38
0.090
Why?
Sinus Thrombosis, Intracranial
1
2010
16
0.090
Why?
Acarbose
1
2010
2
0.090
Why?
Receptors, Adrenergic, beta-2
1
2000
16
0.090
Why?
Indocyanine Green
1
2010
34
0.090
Why?
Hepatocytes
1
2011
178
0.090
Why?
Analgesics, Non-Narcotic
1
2011
117
0.090
Why?
Estradiol
1
2011
221
0.090
Why?
Trachea
1
2000
52
0.080
Why?
Subarachnoid Hemorrhage
1
2010
65
0.080
Why?
Ultrasonography, Interventional
1
2010
137
0.080
Why?
Female
11
2019
27081
0.080
Why?
Radiography
1
2010
485
0.080
Why?
Arkansas
3
2019
1985
0.080
Why?
Hypoglycemic Agents
1
2010
173
0.080
Why?
Dietary Sucrose
2
2010
14
0.080
Why?
Glucocorticoids
1
2000
230
0.080
Why?
Dexamethasone
1
2000
432
0.070
Why?
Cystathionine beta-Synthase
2
2004
17
0.070
Why?
Reproducibility of Results
1
2011
1197
0.070
Why?
Ketorolac Tromethamine
1
2007
2
0.070
Why?
Myocytes, Smooth Muscle
2
2005
87
0.070
Why?
Cyclooxygenase Inhibitors
1
2007
38
0.070
Why?
Recovery of Function
2
2019
191
0.070
Why?
Mice
3
2011
5687
0.070
Why?
Cerebral Veins
1
2007
15
0.070
Why?
Drug Administration Schedule
2
2019
370
0.070
Why?
Cerebral Arteries
1
2007
37
0.070
Why?
Random Allocation
3
2015
289
0.070
Why?
Middle Aged
6
2019
12611
0.060
Why?
Pravastatin
1
2006
18
0.060
Why?
Antineoplastic Agents
1
2014
1172
0.060
Why?
Insulin
2
2010
467
0.060
Why?
Antioxidants
1
2007
239
0.060
Why?
Constriction
1
2004
9
0.060
Why?
Liver
1
2010
1132
0.060
Why?
Platelet Aggregation
1
2005
70
0.060
Why?
Smoke
1
2004
18
0.060
Why?
Muscle, Smooth, Vascular
1
2005
131
0.060
Why?
Blood Platelets
2
2006
251
0.060
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2006
138
0.060
Why?
Cell Division
1
2005
291
0.060
Why?
Databases, Factual
2
2020
673
0.060
Why?
Aged
5
2019
9741
0.060
Why?
Neoplasms
1
2014
1251
0.060
Why?
Emulsions
2
2015
25
0.050
Why?
Cystathionine gamma-Lyase
1
2003
4
0.050
Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.050
Why?
Endothelium, Vascular
1
2005
251
0.050
Why?
Postoperative Period
1
2004
171
0.050
Why?
Saphenous Vein
1
2004
63
0.050
Why?
Arterial Occlusive Diseases
1
2004
79
0.050
Why?
Lower Extremity
1
2004
92
0.050
Why?
Oxidative Stress
1
2007
772
0.050
Why?
Dietary Carbohydrates
1
2003
91
0.050
Why?
Diet
2
2005
568
0.050
Why?
Dietary Fats
1
2003
125
0.050
Why?
Preoperative Care
1
2004
169
0.050
Why?
Folic Acid
1
2003
139
0.050
Why?
Collagen
1
2003
204
0.050
Why?
Renal Dialysis
1
2003
171
0.050
Why?
Retrospective Studies
3
2019
6263
0.050
Why?
Dose-Response Relationship, Drug
3
2011
1372
0.040
Why?
Health Care Sector
1
2020
15
0.040
Why?
Drug Industry
1
2020
38
0.040
Why?
Tomography, X-Ray Computed
2
2018
1164
0.040
Why?
Maximum Tolerated Dose
1
2019
39
0.040
Why?
alpha-Galactosidase
1
2019
9
0.040
Why?
Administration, Intravenous
1
2019
70
0.040
Why?
Disability Evaluation
1
2019
92
0.040
Why?
Multiple Myeloma
1
2013
2998
0.040
Why?
Cell Count
2
2005
150
0.040
Why?
Double-Blind Method
1
2019
708
0.040
Why?
Blotting, Western
2
2005
578
0.030
Why?
Glutamates
1
2016
22
0.030
Why?
Referral and Consultation
1
2019
288
0.030
Why?
Gene Expression Regulation
2
2011
955
0.030
Why?
Angiography
1
2016
128
0.030
Why?
Single-Blind Method
1
2015
114
0.030
Why?
Drug Evaluation, Preclinical
1
2015
145
0.030
Why?
Infusions, Intravenous
1
2015
213
0.030
Why?
Reperfusion Injury
1
2015
86
0.030
Why?
Blood Chemical Analysis
1
2014
28
0.030
Why?
Adult
3
2014
13577
0.030
Why?
Immunohistochemistry
2
2005
957
0.020
Why?
Infusion Pumps, Implantable
1
2011
13
0.020
Why?
Angioplasty
1
2011
20
0.020
Why?
Proliferating Cell Nuclear Antigen
1
2011
68
0.020
Why?
Hyperhomocysteinemia
1
2011
30
0.020
Why?
Liver Regeneration
1
2011
47
0.020
Why?
Jugular Veins
1
2011
34
0.020
Why?
Estrogen Replacement Therapy
1
2011
41
0.020
Why?
Ovariectomy
1
2011
115
0.020
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2011
57
0.020
Why?
Statistics, Nonparametric
1
2011
192
0.020
Why?
Chi-Square Distribution
1
2011
277
0.020
Why?
Vascular Endothelial Growth Factor A
1
2011
182
0.020
Why?
Adrenergic beta-2 Receptor Agonists
1
2000
3
0.020
Why?
Ultrasonography, Doppler, Pulsed
1
2010
2
0.020
Why?
Coloring Agents
1
2010
66
0.020
Why?
Injections, Intravenous
1
2010
137
0.020
Why?
Phlebography
1
2010
60
0.020
Why?
Isoproterenol
1
2000
56
0.020
Why?
Luciferases
1
2000
49
0.020
Why?
Mice, Inbred Strains
1
2010
160
0.020
Why?
Adrenergic beta-Agonists
1
2000
43
0.020
Why?
Epithelium
1
2000
66
0.020
Why?
Alanine Transaminase
1
2010
119
0.020
Why?
Regional Blood Flow
1
2010
109
0.020
Why?
Blood Flow Velocity
1
2010
99
0.020
Why?
Cyclic AMP
1
2000
90
0.020
Why?
Propranolol
1
2000
79
0.020
Why?
Norepinephrine
1
2000
114
0.020
Why?
Epinephrine
1
2000
97
0.020
Why?
Transfection
1
2000
356
0.020
Why?
Cell Membrane
1
2000
246
0.020
Why?
Ultrasonography
1
2011
435
0.020
Why?
Transcription, Genetic
1
2000
361
0.020
Why?
DNA
1
2011
535
0.020
Why?
Cell Line
1
2000
988
0.020
Why?
Blood Glucose
1
2010
446
0.020
Why?
Malondialdehyde
1
2007
51
0.020
Why?
Platelet Activation
1
2007
45
0.020
Why?
Triiodobenzoic Acids
1
2007
9
0.020
Why?
Glutathione
1
2007
299
0.020
Why?
Aged, 80 and over
1
2013
3226
0.020
Why?
Drug Combinations
1
2006
127
0.020
Why?
Contrast Media
1
2007
192
0.020
Why?
Dizocilpine Maleate
1
2005
15
0.020
Why?
Cholesterol
1
2006
150
0.020
Why?
Interleukin-1
1
2005
105
0.020
Why?
Matrix Metalloproteinase 9
1
2005
88
0.020
Why?
Excitatory Amino Acid Antagonists
1
2005
51
0.020
Why?
Homocystine
1
2004
8
0.020
Why?
DNA, Complementary
1
2005
133
0.020
Why?
Platelet Function Tests
1
2004
17
0.010
Why?
Cell Culture Techniques
1
2005
96
0.010
Why?
C-Reactive Protein
1
2006
144
0.010
Why?
Aorta, Thoracic
1
2005
95
0.010
Why?
Cotinine
1
2004
21
0.010
Why?
Probability
1
2004
164
0.010
Why?
Cell Movement
1
2005
247
0.010
Why?
RNA
1
2005
163
0.010
Why?
Reference Values
1
2004
307
0.010
Why?
Biopsy, Needle
1
2004
178
0.010
Why?
Severity of Illness Index
1
2007
978
0.010
Why?
Ultrasonography, Doppler, Duplex
1
2004
21
0.010
Why?
Arginine
1
2005
187
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
572
0.010
Why?
Platelet Adhesiveness
1
2003
13
0.010
Why?
Signal Transduction
1
2000
1624
0.010
Why?
Young Adult
1
2013
4102
0.010
Why?
Elastin
1
2003
22
0.010
Why?
Nitric Oxide
1
2005
259
0.010
Why?
Polytetrafluoroethylene
1
2003
32
0.010
Why?
Anastomosis, Surgical
1
2003
66
0.010
Why?
Dogs
1
2003
186
0.010
Why?
Vascular Patency
1
2003
83
0.010
Why?
Extracellular Matrix
1
2003
109
0.010
Why?
Graft Occlusion, Vascular
1
2003
74
0.010
Why?
Gene Expression
1
2005
610
0.010
Why?
RNA, Messenger
1
2005
1089
0.010
Why?
Adolescent
1
2013
6443
0.010
Why?
Cells, Cultured
1
2005
1571
0.010
Why?
Cell Proliferation
1
2005
985
0.010
Why?
Models, Biological
1
2003
716
0.010
Why?
Brown's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description